Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice by unknown
Exercise-induced mitochondrial p53 repairs
mtDNA mutations in mutator mice
Safdar et al.
Safdar et al. Skeletal Muscle  (2016) 6:7 
DOI 10.1186/s13395-016-0075-9
RESEARCH Open Access
Exercise-induced mitochondrial p53 repairs
mtDNA mutations in mutator mice
Adeel Safdar1,2,3, Konstantin Khrapko6, James M. Flynn7, Ayesha Saleem2, Michael De Lisio1, Adam P. W. Johnston1,
Yevgenya Kratysberg6, Imtiaz A. Samjoo4, Yu Kitaoka2, Daniel I. Ogborn4, Jonathan P. Little8, Sandeep Raha2,
Gianni Parise1,5, Mahmood Akhtar3, Bart P. Hettinga2, Glenn C. Rowe9, Zoltan Arany10, Tomas A. Prolla11,12 and
Mark A. Tarnopolsky2,3*
Abstract
Background: Human genetic disorders and transgenic mouse models have shown that mitochondrial DNA
(mtDNA) mutations and telomere dysfunction instigate the aging process. Epidemiologically, exercise is associated
with greater life expectancy and reduced risk of chronic diseases. While the beneficial effects of exercise are well
established, the molecular mechanisms instigating these observations remain unclear.
Results: Endurance exercise reduces mtDNA mutation burden, alleviates multisystem pathology, and increases
lifespan of the mutator mice, with proofreading deficient mitochondrial polymerase gamma (POLG1). We report
evidence for a POLG1-independent mtDNA repair pathway mediated by exercise, a surprising notion as POLG1 is
canonically considered to be the sole mtDNA repair enzyme. Here, we show that the tumor suppressor protein p53
translocates to mitochondria and facilitates mtDNA mutation repair and mitochondrial biogenesis in response to
endurance exercise. Indeed, in mutator mice with muscle-specific deletion of p53, exercise failed to prevent mtDNA
mutations, induce mitochondrial biogenesis, preserve mitochondrial morphology, reverse sarcopenia, or mitigate
premature mortality.
Conclusions: Our data establish a new role for p53 in exercise-mediated maintenance of the mtDNA genome and
present mitochondrially targeted p53 as a novel therapeutic modality for diseases of mitochondrial etiology.
Keywords: Skeletal muscle, Satellite cells, Endurance exercise, p53, Mitochondrial DNA mutations, Mutator mouse,
Oxidative stress, Telomere, Apoptosis, Senescence
Background
The universality of the aging phenomenon has evoked
great interest in unveiling regenerative remedies and re-
juvenation medicine designed to evade molecular insti-
gators of mammalian aging. Molecular investigations of
age-related pathologies implicate mitochondrial DNA
(mtDNA) mutations as one of the primary instigators
driving multisystem degeneration, stress intolerance, and
energy deficits [1]. It is intuitive to assume that the de
novo mtDNA mutations observed during aging are due
to accumulated, unrepaired oxidative damage, but some
evidence actually suggests that mtDNA replication er-
rors may be the more important culprit [2]. The demon-
stration that multiple aspects of aging are accelerated in
mutator mice harboring error-prone mitochondrial poly-
merase gamma provides support for the causal role of
mtDNA replication errors in instigating mammalian
aging [3, 4]. Similar phenotypes have also been reported
in telomerase-deficient mice [5], where telomere dys-
function is associated with impaired mitochondrial bio-
genesis and metabolic failure resulting in progressive
tissue atrophy, stem cell depletion, organ system failure,
and impaired tissue injury responses as seen with aging
[5]. Indeed, epidemiological studies have correlated de-
creased telomere length in peripheral blood leukocytes,
with higher mortality rates in individuals more than
60 years old [6]. Furthermore, a recent study in
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centenarians and their offspring found a positive link be-
tween telomere length and longevity; in particular, those
with longer telomeres had an overall improved health
profile, with decreased incidence of age-associated dis-
eases, better cognitive function, and improved lipid pro-
files relative to controls [7].
The epidemic emergence of modern chronic diseases
largely stems from the adoption of a sedentary lifestyle
and excess energy intake [8]. There is incontrovertible
evidence that endurance exercise extends life expectancy
and reduces the risk of chronic diseases in both rodents
and humans [9, 10]. We have previously shown that en-
durance exercise effectively rescued progeroid aging in
mutator mice concomitant with a reduction in mtDNA
mutations, despite an inherent defect in mitochondrial
polymerase gamma (POLG1) proofreading function [11].
Exercise has also been shown to increase telomerase ac-
tivity and reduce senescence markers [12]. These find-
ings suggest a link between exercise-mediated metabolic
adaptations and genomic (nuclear and mitochondrial)
stability; however, the identity of this metabolic link re-
mains unknown. In this study, we have utilized PolG
mice to investigate the mitochondrial-telomere dysfunc-
tion axis in the context of progeroid aging, and to
elucidate how exercise counteracts mitochondrial
dysfunction and mtDNA mutation burden through




Heterozygous mice (C57Bl/6J, PolgA+/D257A) for the
mitochondrial polymerase gamma knock-in mutation
were a kind gift from Dr. Tomas A. Prolla, University
of Wisconsin-Madison, USA [4]. We generated homo-
zygous knock-in mtDNA mutator mice (PolG; Pol-
gAD257A/D257A) and littermate wild-type (WT; PolgA
+/+) from heterozygous mice-derived colony main-
tained at the McMaster University Central Animal Fa-
cility as previously described [11]. Muscle-specific p53
knock-out mice (p53 MKO) were bred by crossing
p53 flox mice (Trp53tm1Brn/J) with muscle-creatine
kinase Cre recombinase mice (Tg(Ckmm-cre)5Khn/J)
purchased from Jackson Laboratories. We generated
genetically modified homozygous knock-in mtDNA
mutator mice with muscle-specific p53 knockout
(PolG-p53 MKO), by crossing heterozygous mice
(PolgA+/D257A) with p53 MKO mice. During breeding,
all animals were housed three to five per cage in a
12-h light/dark cycle and were fed ad libitum
(Harlan-Teklad 8640 22/5 rodent diet) after weaning.
The presence of the polymerase gamma homozygous
knock-in mutation was confirmed as previously
described [4].
Endurance exercise protocol
Endurance exercise protocol and tissue harvesting was
carried out, as previously described, using an independ-
ent cohort of mice [11]. Briefly, at 3 months of age, mice
were housed individually in micro-isolator cages in a
temperature- and humidity-controlled room and main-
tained on a 12-h light–dark cycle with food and water
ad libitum [13]. PolG mice and PolG-p53 MKO mice
were randomly assigned to sedentary (PolG-SED or
PolG-p53 MKO-SED) or forced-endurance (PolG-END
or PolG-p53 MKO-END) exercise groups (n = 5–20/
group; ♀ =♂). None of the mice had been previously
subjected to a structured exercise regiment. One week
of pre-training was allowed to acclimatize mice in en-
durance exercise groups to the treadmill. Mice in endur-
ance exercise groups were subjected to forced treadmill
exercise (Eco 3/6 treadmill; Columbus Instruments,
Columbus, Ohio) three times per week at 15 m/min for
45 min for 6 months. A 5-min warm-up and cool-down
at 8 m/min were also included. PolG mice were age- and
sex-matched with sedentary littermate WT mice (n = 20;
♀ =♂), which served as controls for the study to assess
if endurance exercise intervention can molecularly bring
PolG mice to normalcy. At 8 months of age, animals
were euthanized and tissues were collected for molecular
analyses. The study was approved by the McMaster
University Animal Research and Ethics Board under the
global Animal Utilization Protocol # 12-03-09, and the
experimental protocol strictly followed guidelines put
forth by the Canadian Council of Animal Care.
Endurance stress test
The mice were subjected to four separate endurance
stress tests over to indirectly assess improvements in
aerobic capacity with exercise as previously described
[11]. Briefly, animals from all groups were placed in indi-
vidual lanes on the treadmill and allowed to acclimatize
for 30 min to eliminate any confounding effects due to
stress or anxiety related to a new environment. The test
began with a 5-min warm-up session at 8 m/min,
followed by +1 m/min increase in speed every 2 min
until the mouse reached exhaustion. A low-intensity
electrically stimulus was provided to ensure compliance.
Time to exhaustion (min) was recorded when the mouse
sat at the lower end of the treadmill, near a shock bar,
for >10 s and was unresponsive to further stimulation to
continue running.
Survival analysis
An independent cohort of animals from all groups was
used to carry out survival analyses as previously de-
scribed [11], and Kaplan–Meier survival curves were cal-
culated using GraphPad Prism 4.0.
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Tissue harvesting
Tissues were collected at the time of euthanasia as previ-
ously described [11]. Immediately following cervical dis-
location, the chest cavity was exposed and the heart was
removed rapidly, followed by the skeletal muscle (quad-
riceps femoris). The skeletal muscle (quadriceps femoris,
tibialis anterior, and soleus) and heart were either (i) col-
lected in RNase-free cryovials, immediately immersed in
liquid nitrogen, and stored at −80 °C for later analysis of
DNA, RNA, protein, and enzyme activity or (ii) immedi-
ately rinsed with phosphate buffer saline (PBS) and used
for skeletal muscle and heart mitochondrial and nuclear
fractionations.
Hematopoietic stem and progenitor cell isolation
Mouse hematopoietic stem and progenitor cells (HSC)
were isolated according to the method of Ema et al. with
minor modifications [14]. Marrow was flushed from the
femur and tibia using a 25-g needle, passed through a 50-
μm sieve and counted with a hemocytometer. Cells were
incubated with primary antibodies for 90 min at 4 °C
followed by 20 min incubation in the appropriate second-
ary antibody at 4 °C. Lineage negative, and Sca-1 and c-
Kit positive (LSK) population enriched for stem cells
were sorted using the EPICS ALTRA™ fluorescence-
activated cell sorter (Beckman Coulter, Mississauga,
ON) with gating strategies established using single-
stained controls. The following antibodies were used:
lineage panel (BD Pharmingen™, Mississauga, ON),
anti-mouse Sca-1 Clone: E13-161.7 (BD Pharmingen™,
Mississauga, ON), anti-mouse c-Kit Clone: 2B8
(eBioscience, San Diego, CA), and streptavidin (Bio-
Source, Burlington, ON).
Satellite cell isolation
Primary skeletal muscle satellite cells (SC) were isolated
from WT, PolG-SED, and PolG-END mice using the
methods described previously [15] and subsequently
purified by fluorescence-activated cell sorting. Briefly,
the hind limb skeletal muscles were carefully dissected,
cleaned of fat and washed in cold PBS. Cells were re-
leased by mulching the tissue with scissors and incuba-
tion in a collagenase/dispase solution three times,
12 min each, at 37 °C with further mechanical disruption
using a pipette between incubations. Following passage
through 70 and 30 μm filters, cells were stained using
primary antibody to c-met conjugated to PE (1:200,
eBioscience, San Diego, CA) and subjected to FACS
sorting (EPICS ALTRA™, Beckman Coulter, Mississauga,
ON). SC were pelleted in RNase-free cryovials, immedi-
ately immersed in liquid nitrogen, and stored at −80 °C
for later analyses.
Mouse embryonic fibroblast isolation and reporter assay
Mouse embryonic fibroblasts (MEFs) were generated
using standard techniques from WT (p53+/+) and p53
knockout (KO) mice (p53−/−). Cell used in the experi-
ments were from passages 4–5. Promoter sequence for
PGC-1α was amplified by PCR from mouse muscle gen-
omic DNA and cloned into the pGL4 luciferase reporter
vector (Promega, Madison, WI). The pG13-luc plasmid
containing 13 copies of a synthetic p53 DNA binding
site was used as a positive control (which has been com-
prehensively characterized in Jackson et al., 2001 and
Kern et al., 1991). A GFP expressing plasmid was used
to normalize transfection efficiency. p53+/+ and p53−/−
MEFs were transfected (Lipofectamine 2000, Invitrogen,
Burlington, ON) with either empty pGL4, pG13-luc
(positive control), or pGL4-PGC-1α vectors. p53 tran-
scriptional activity was measured using Bright-Glo™ lu-
ciferase reporter assay system (Promega, Madison, WI).
Total RNA isolation from skeletal muscle and heart
Total RNA was isolated from ~25 mg of the skeletal
muscle (quadriceps femoris) and heart using the
Qiagen total RNA isolation kit (Qiagen, Mississauga,
ON) [11, 13]. RNA samples were treated with
RNase-free DNase on Qiagen spin-columns (Qiagen,
Mississauga, ON) to remove DNA contamination.
RNA integrity and concentration were assessed using
the Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA) [13]. The average RIN (RNA integrity
number) value for all samples was 9.64 ± 0.20 (scale
1–10), ensuring a high quality of isolated RNA.
RNA, DNA, and protein isolation from HSC and SC
Total RNA, DNA, and protein were isolated from HSC
and SC using the Qiagen AllPrep DNA/RNA Mini Kit
(Qiagen, Mississauga, ON) according to the manufac-
turer’s instructions.
Microarray analysis
Total RNA was extracted from skeletal muscle (quadri-
ceps femoris) using the Qiagen RNeasy Micro kit
(Qiagen, Mississauga, ON) and processed on Qiagen’s
QIAcube (Qiagen, Mississauga, ON) using the standard
manufacturer’s protocol. The samples were then checked
for quality using Nanodrop 2000 (Thermo Scientific,
Wilmington, DE) and Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA). TransPlex Whole Tran-
scriptome Amplification kit (Sigma-Aldrich®, Oakville,
ON) was used to amplify complementary (cDNA) from
the muscle RNA samples according to the manufac-
turer’s instructions. Samples were amplified for 25 cycles
using the recommended cycling parameters. All samples
were subsequently purified using Qiagen’s QIAquick
PCR Purification kit (Qiagen, Mississauga, ON) and
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processed on Qiagen’s QIAcube (Qiagen, Mississauga,
ON) using the standard “Cleanup QIAquick PCR for
amplification reactions” (Version 4) protocol. Samples
were purified and examined using Nanodrop 2000
(Thermo Scientific, Wilmington, DE) and Agilent 2100
Bioanalyzer DNA 7500 chip (Agilent Technologies, Palo
Alto, CA) to ensure proper yield and quality of amplifi-
cation. To perform the microarray hybridization, 2 μg of
cDNA from each sample was labeled using NimbleGen’s
One Color Labeling kit (Cat.# 05223555001; Roche
NimbleGen Inc., Madison, WI) according to the manu-
facturer’s protocol. Five micrograms of Cy3 labeled
samples were hybridized to Mus musculus 12x135k,
NimbleGen Gene Expression Arrays (Cat.# 05543797001;
Roche NimbleGen Inc., Madison, WI), washed, and
scanned according to manufacturer’s protocol. NimbleGen
gene expression arrays were scanned using an Axon
GenePix 4200A scanner (Molecular Devices Inc., Down-
ingtown, PA) with settings of 100 POW and 300–350
photomultiplier (PMT). Pair files were generated for each
array using NimbleScan software (Roche NimbleGen Inc.,
Madison, WI). Resulting array data was analyzed with Bio-
conductor software (Bioconductor, Seattle, WA) in which
the data were normalized and tested for significantly dif-
ferentially expressed genes which were assessed based
upon a 5 % false discovery rate (FDR). The gene array data
reported here is deposited in Gene Expression Omnibus
(Accession Number: GSE75869) public functional genom-
ics data repository. The resulting data were input into In-
genuity Pathway Analysis (Ingenuity® Systems, Redwood
City, CA) to determine the over-represented gene categor-
ies using strict association. The normalized expression in
these categories was plotted in a heat map using R script
and Bioconductor software (Bioconductor, Seattle, WA).
Real-time quantitative PCR
The messenger RNA (mRNA) expression of peroxisome
proliferator-activated receptor gamma co-activator 1
alpha (PGC-1α), mitochondrial transcription factor A
(TFAM), estrogen-related receptor alpha (ERRα), 5-
aminolevulinate synthase (ALAS), cytochrome c oxidase
subunit-I (COX-I), cytochrome c oxidase subunit-IV
(COX-IV), complex I NADH dehydrogenase subunit 1
(ND1), complex V subunit ATPase 6 (ATPase 6), cyclin-
dependent kinase inhibitor 1A (p21WAF1), cyclin-
dependent kinase inhibitor 2A (p16INK4A), and growth
arrest and DNA-damage-inducible beta (GADD45B)
were quantified using 7300 Real-time PCR System (Ap-
plied Biosystems Inc., Foster City, CA) and SYBR® Green
chemistry (PerfeCTa SYBR
® Green Supermix, ROX,
Quanta BioSciences, Gaithersburg, MD) as previously
described [11, 13]. First-strand cDNA synthesis from
1 μg of total RNA was performed with random primers
using a high-capacity cDNA reverse transcription kit
(Applied Biosystems Inc., Foster City, CA) [11]. Forward
and reverse primers for the aforementioned genes
(Additional file 1: Table S2) were designed based on se-
quences available in GenBank using the online MIT
Primer 3 designer software (developed at Whitehead In-
stitute and Howard Hughes Medical Institute by Steve
Rozen and Helen Skaletsky) and were confirmed for spe-
cificity using the basic local alignment search tool. β-2
microglobulin was used as a control house-keeping gene,
as its expression was not affected with the experimental
intervention (data not shown). All samples were run in
duplicate simultaneously with a negative control which
contained no cDNA. Melting point dissociation curves
generated by the instrument were used to confirm the
specificity of the amplified product.
Tissue total DNA isolation
Total DNA (genomic and mtDNA) was isolated from
~15 mg of the skeletal muscle (soleus) and heart using
the QIAamp DNA Mini kit (Qiagen, Mississauga, ON)
[11, 16]. DNA samples were treated with RNase
(Fermentas, Mississauga, ON) to remove RNA contam-
ination. DNA concentration and quality were assessed
using Nanodrop 2000 (Thermo Scientific, Wilmington,
DE).
mtDNA copy number analysis
Mitochondrial DNA copy number, relative to the diploid
chromosomal DNA content, was quantitatively analyzed
from the skeletal muscle (soleus), heart, primary
hematopoietic stem cells, primary satellite cells, and pri-
mary fibroblasts using ABI 7300 real-time PCR (Applied
Biosystems, CA) [11, 16]. Primers were designed around
COX-II region of the mitochondrial genome (Additional
file 1: Table S2). Nuclear β-globin gene was used as a
housekeeping gene (Additional file 1: Table S2).
Average telomere length
Average telomere length was measured in heart, primary
hematopoietic stem cells, and primary satellite cell gen-
omic DNA using a real-time quantitative PCR method
as previously described [17]. The premise of this assay is
to measure an average telomere length ratio by quantify-
ing telomeric DNA with specially designed primer se-
quences and dividing that amount by the quantity of a
single-copy gene [17]. All samples were run using a 7300
Real-time PCR System (Applied Biosystems Inc., Foster
City, CA) and SYBR® Green chemistry (PerfeCTa SYBR
®
Green Supermix, ROX, Quanta BioSciences, Gaithers-
burg, MD). A single-copy gene, 36B4, which encodes for
the acidic ribosomal phosphoprotein PO, was used as a
control for amplification for every sample performed
[17, 18]. Each PCR reaction for the telomere and 36B4
included 12.5 μL of 1x SYBR® Green master mix
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(PerfeCTa SYBR
® Green Supermix, ROX, Quanta BioSci-
ences, Gaithersburg, MD), 300 nM each of the forward
and reverse telomere or 36B4 primers (Additional file 1:
Table S2), 20 ng genomic DNA, and enough DNase/
RNase-free H2O (Applied Biosystems Inc., Foster City,
CA) to yield a 25-μL reaction. Cycling conditions for
telomere are as follows: 95 °C for 10 min followed by
30 cycles of data collection at 95 °C for 15 s and a 56 °C
anneal-extend step for 1 min. Cycling conditions for
36B4 are as follows: 95 °C for 10 min followed by 35 cy-
cles of data collection at 95 °C for 15 s, with 52 °C an-
nealing for 20 s, followed by extension at 72 °C for 30.
Each sample was analyzed in duplicate, and the ratio of
telomere:36B4 was calculated. The average of these ra-
tios was reported as the average telomere length ratio
(ATLR).
Whole tissue lysate
Total protein was extracted from tissue samples as pre-
viously described [11]. Briefly, ~30 mg of the skeletal
muscle (quadriceps femoris) and heart were homoge-
nized on ice in a 2-mL Wheaton glass homogenizer
(Fisher Scientific, Ottawa, ON) with 25 volumes of phos-
phate homogenization buffer [50 mM KPi, 5 mM EDTA,
0.5 mM DTT, 1.15 % KCl supplemented with a
Complete Mini, ETDA-free protease inhibitor cocktail
tablet and a PhosSTOP, phosphatase inhibitor cocktail
tablet (Roche Applied Science, Mannhein, Germany) per
10 mL of buffer]. The lysate was centrifuged at 600g for
15 min at 4 °C to pellet cellular debris. The supernatant
was aliquoted, snap frozen in liquid nitrogen, and stored
at −80 °C until further analysis.
Nuclear fractionation
Nuclear fractions were prepared from 40 mg of the
freshly obtained skeletal muscle (quadriceps femoris),
heart, primary satellite cells, and primary fibroblasts
using a commercially available nuclear extraction kit
(Pierce NE-PER®, Rockford, IL) as previously described
[11, 16]. Briefly, samples were homogenized in CER-I
buffer containing protease inhibitor cocktail Complete,
ETDA-free (Roche Applied Science, Mannheim,
Germany) using an electronic homogenizer (Pro 250,
Pro Scientific, Oxford, CT, USA). Pellets containing nu-
clei were obtained by centrifugation at 16,000g for
10 min at 4 °C and were subsequently washed four times
in PBS to remove cytosolic contaminating proteins. Nu-
clear proteins were extracted in NER buffer supple-
mented with protease inhibitors [11]. Enrichment and
purity of nuclear fractions were confirmed by the abun-
dance of nuclear histone H2B and absence of the cyto-
solic protein lactate dehydrogenase in Western blot
analyses as previously shown by our group [16].
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assay was per-
formed using an EZ-ChIP™ kit (Millipore, Billerica, MA)
as previously described [11]. Twenty-milligram piece of
the quadriceps femoris muscle was cross-linked in 5 mL of
phosphate-buffered saline containing 1 % formaldehyde
for 10 min at room temperature. One milliliter of 10X gly-
cine was added to stop fixation. Muscles were then ho-
mogenized in 1 mL of SDS lysis buffer supplemented with
protease inhibitor cocktail Complete, ETDA-free (Roche
Applied Science, Mannheim, Germany). Chromatin was
sheared by sonicating each sample on ice using a Branson
Digital Sonifier® S-450D (output 20 %, 4 times for 20 s,
with a 20-s pause each time; Branson Ultrasonics Corpor-
ation, Danbury, CT). Following centrifugation at 10,000×g
at 4 °C for 10 min, the supernatant containing 1 mg of
protein was diluted to 1 mL with dilution buffer. Ten mi-
crograms of anti-p53 (FL-393) antibody (Santa Cruz Bio-
technology Inc., Santa Cruz, CA) was added per sample
and incubated overnight at 4 °C. Anti-IgG antibody was
used as a non-specific control. Sixty microliters of protein
G-agarose was added, and the sample was mixed for 1 h
at 4 °C with rotation. Precipitated complexes were eluted
in 100 μL of elution buffer, and cross-linking was reversed
by the addition of 8 μL of 5 M NaCl per sample followed
by incubation at 65 °C for 10 h. Co-immunoprecipitated
DNA was purified according to the manufacturer’s in-
structions. Primers were designed to amplify the p53 bind-
ing regions (−564 and −954) of the PGC-1α promoter
(Additional file 1: Table S2). The amount of PGC-1α pro-
moter immunoprecipitated with p53 was quantified using
the 7300 Real-time PCR System (Applied Biosystems Inc.,
Foster City, CA) and SYBR® Green chemistry (PerfeCTa
SYBR® Green Supermix, ROX, Quanta BioSciences,
Gaithersburg, MD). Purified DNA from the input sample
that did not undergo immunoprecipitation was PCR-
amplified using of β-globin primers (Additional file 1:
Table S2) and was used to normalize signals from ChIP
assays.
Mitochondrial fractionation
Mitochondrial fractions were isolated using differential
centrifugation as previously outlined [11]. Briefly, the
skeletal muscle (quadriceps femoris and tibialis anterior),
heart, primary satellite cells, and primary fibroblasts
were finely minced and homogenized on ice in 1:10 (wt/
vol) ice-cold isolation buffer A (10 mM sucrose, 10 mM
Tris/HCl, 50 mM KCl, and 1 mM EDTA, and 0.2 % fatty
acid-free BSA, pH 7.4, supplemented with protease in-
hibitor cocktail Complete, ETDA-free [Roche Applied
Science, Mannheim, Germany]) using a Potter-Elvehjem
glass homogenizer. The resulting homogenates were
centrifuged for 15 min at 700g, and the subsequent su-
pernatants were centrifuged for 20 min at 12,000g. The
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mitochondrial pellets from 12,000g spin were washed
and then re-suspended in a small volume of ice-cold iso-
lation buffer B (10 mM sucrose, 0.1 mM EGTA/Tris,
and 10 M Tris/HCl, pH 7.4, supplemented with protease
inhibitor cocktail Complete, ETDA-free [Roche Applied
Science, Mannheim, Germany]). All centrifugation steps
were carried out at 4 °C. The mitochondrial pellets were
immediately frozen at −80 °C for further biochemical
analyses. Enrichment and purity of mitochondrial frac-
tions were confirmed by the abundance of mitochondrial
cytochrome c oxidase subunit IV protein and absence of
the nuclear histone H2B and the cytosolic protein lactate
dehydrogenase in Western blot analyses as previously
shown by our group [16].
Mitochondrial co-immunoprecipitation assay
Mitochondrial co-immunoprecipitation assay was per-
formed on isolated mitochondrial fractions using Pierce
Co-Immunoprecipitation Kit (Pierce, Rockford, IL) as
previously described [16]. Briefly, mitochondrial frac-
tions were homogenized in lysis buffer (0.025 M Tris,
0.15 M NaCl, 0.001 M EDTA, 1 % NP-40, 5 % glycerol,
pH 7.4) supplemented with protease inhibitor cocktail
Complete, ETDA-free (Roche Applied Science,
Mannheim, Germany). Two milligrams of mitochondrial
fraction was pre-cleared by incubation with 100 μL of
control agarose resin to minimize non-specific binding.
Forty micrograms of anti-p53 (FL-393) antibody (Santa
Cruz Biotechnology Inc., Santa Cruz, CA) was covalently
coupled onto an amine-reactive resin. The pre-cleared
lysates were subsequently incubated with antibody-
coupled beads overnight at 4 °C. Co-immunoprecipitates
were collected by centrifugation, boiled in 50 μL of
Laemmli sample buffer, and used for immunoblot ana-
lysis for POLG1 (a kind gift of Dr. William C. Copeland,
National Institutes of Health) or anti-Tfam (sc23588, A-
17; Santa Cruz Biotechnology Inc., Santa Cruz, CA) anti-
body. Anti-IgG antibodies were used as a non-specific
control.
mtDNA immunoprecipitation assay
mtDNA immunoprecipitation was performed on skeletal
muscle mitochondrial fraction that was cross-linked and
sonicated as previously described [16, 19]. One milli-
gram of mitochondrial fraction was pre-cleared in 25 %
v/v pre-clearing matrix F (Santa Cruz Biotechnology,
Santa Cruz, CA) overnight at 4 °C. The supernatant was
then incubated with 20 μg of anti-p53 (FL-393) antibody
(Santa Cruz Biotechnology Inc., Santa Cruz, CA) and
ExactaCruz™ F matrix (Santa Cruz Biotechnology, Santa
Cruz, CA) [20] with mixing by end-over-end inversion
overnight at 4 °C in the presence of 5 μg of shared sal-
mon sperm DNA (Sigma-Aldrich®, Oakville, ON) to re-
duce non-specific DNA-bead interactions. Anti-IgG
antibodies were used as a non-specific control. The
matrix was centrifuged at 16,000g for 30 s, and the pellet
matrix-immune complex precipitate was washed four
times under stringent conditions (50 mM Tris-HCl, pH
7.4, 500 mM NaCl, 2 mM EDTA) and incubated over-
night at 65 °C in the presence of 1 % SDS for cross-
linking reversion. DNA was extracted from supernatants
using the QIAamp DNA Mini kit (Qiagen, Mississauga,
ON) according to the manufacturer’s instructions.
mtDNA COX-II and cytochrome b regions (Additional
file 1: Table S2) were quantified using 7300 Real-time
PCR System (Applied Biosystems Inc., Foster City, CA)
and SYBR® Green chemistry (PerfeCTa SYBR
® Green
Supermix, ROX, Quanta BioSciences, Gaithersburg,
MD), as previously described [16].
Western blotting and markers of oxidative damage
Protein concentrations of whole tissue lysates, and mito-
chondrial and nuclear fractions were determined using a
commercial assay (BCA Protein Assay, Pierce, Rockford,
IL). Proteins were resolved on 10 or 12.5 % SDS-PAGE
gels depending on the molecular weight of the protein of
interest. The gels were transferred onto Hybond® ECL
nitrocellulose membranes (Amersham, Piscataway, NJ)
and immunoblotted using the following commercially
available primary antibodies: MitoProfile® Total OXPHOS
Rodent cocktail (MS604) antibody (MitoSciences, Eugene,
OR); anti-PGC-1α (2178), anti-VDAC (4866), and anti-α/
β-tubulin (2148) antibodies (Cell Signaling Technology,
Denver, MA); anti-p53 (MABE283-PAb421) antibody
(EMD Millipore); anti-Tfam (sc-23588) and anti-NRF-1
(sc-33771) antibodies (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA); anti-POLG1 antibody (a kind gift of Dr.
William C. Copeland, National Institutes of Health, USA);
anti-citrate synthase antibody (a kind gift of Dr. Brian H.
Robinson, The Hospital for Sick Children, Canada); anti-
4-HNE (ab48506), anti-SOD2 (ab13533), anti-catalase
(ab1877), and anti-p21WAF1 (ab7960) antibodies (Abcam,
Cambridge, MA); anti-Pax7 (Developmental Studies
Hybridoma Bank, University of Iowa, Iowa City, IO); and
anti-ERRα (EPR46Y) and anti-actin (NB600-535) anti-
bodies (Novus Biologicals, Littleton, CO) [11, 16]. The
carbonylated protein content in whole tissue lysates and
mitochondrial fractions was quantified by Western blot
using OxyBlot Protein Detection kit (S7150; Millipore,
Bedford, MA) as per manufacturer’s instructions. All anti-
bodies were used at 1:1000 dilution, except for anti-actin
(1:10,000). Membranes were then incubated with the
appropriate anti-mouse or anti-rabbit horse radish
peroxidase-linked secondary antibody (1:10,000) and visu-
alized by enhanced chemiluminescence detection reagent
(Amersham, Piscataway, NJ). Relative intensities of the
protein bands were digitally quantified by using NIH
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Image J, version 1.37, analysis software (Scion Image,
NIH).
ROS assay
Mitochondrial H2O2 production was measured using the
Amplex® Red Hydrogen Peroxide assay (A22188; Invitro-
gen, Burlington, ON) as per manufacturer’s instructions.
Briefly, 40 μg of mitochondrial fraction was diluted in
50 μL reaction buffer (125 mM KCl, 10 mM HEPES,
5 mM MgCl2, 2 mM K2HPO4, pH 7.44) to determine
mitochondrial respiratory chain complex I (5 mM pyru-
vate/malate) or complex II (5 mM succinate) driven
H2O2 production with and without inhibitors (0.5 μM
rotenone, complex I inhibitor, and 0.5 μM antimycin A,
complex III inhibitor). Mitochondrial H2O2 production
was measured after the addition of 50 μL of reaction
buffer containing horseradish peroxidase and Amplex®
Red. Fluorescence was followed at an excitation wave-
length of 545 nm and an emission wavelength of 590 nm
for 5 min using fluorescence microplate reader (Tecan
Safire, MTX Lab Systems, Inc., Vienna, VA). The slope
of the increase in fluorescence is converted to the rate of
H2O2 production with a standard curve. All of the assays
were performed at 25 °C. The results are expressed as
pmoles.min−1.mg protein−1.
Mitochondrial respiratory chain complex I and IV enzyme
activity
Mitochondrial ETC complex I and complex IV activities
were determined in tissue lysates following established
protocols [11, 21–23]. All samples were analyzed in du-
plicates on the Cary UV-vis spectrophotometer (Varion,
Inc., Palo Alto, CA).
Superoxide dismutase and catalase enzyme activity
Muscle total superoxide dismutase (Mn-SOD and Cu/Zn-
SOD) activity was determined in muscle lysates by meas-
uring the kinetic consumption of superoxide radical (O2
−)
by SOD in a competitive reaction with cytochrome c, as
previously described [20]. Absorption was recorded at
550 nm and was observed every 15 s for 2 min at 37 °C.
One unit (U) of SOD activity was defined as the amount
of enzyme that caused a 50 % inhibition of the reduction
of cytochrome c. Total SOD activity was expressed in
U.mg of protein−1. In a separate cuvette, the same sample
was analyzed under identical conditions in the presence of
0.2 M KCN (pH 8.5–9.5), a potent inhibitor of cytosolic
Cu/Zn-SOD [24], for determination of mitochondrial Mn-
SOD activity. Cu/Zn-SOD activity was approximated by
subtracting Mn-SOD activity from total SOD activity.
Both Mn-SOD and Cu/Zn-SOD activity were expressed in
U.mg protein−1. Catalase activity was determined by
measuring the kinetic decomposition of H2O2 as previ-
ously described [25]. Catalase activity was measured by
combining 960 μL of K2HPO4 buffer (50 mM with
50 mM EDTA and 0.01 % Triton X-100, pH 7.2–7.4) with
30 μL of muscle homogenate. Ten microliters of H2O2
(1 M) was added to the cuvette and mixed by inversion to
initiate the reaction. Absorbance was measured at 240 nm
every 15 s for 2 min. Catalase activity was calculated and
reported in μmol · min−1 · mg protein−1. All samples were
analyzed in duplicates on the Cary UV-vis spectrophotom-
eter (Varion, Inc., Palo Alto, CA).
Caspase-3 and caspase-9 enzyme activity
Caspase-3 and caspase-9 enzyme activity was measured
using fluorometric protease assays caspase-3/CPP32 and
caspase-9/Mch6, respectively (Biovision, Mountain View,
CA) according to manufacturer’s instructions. Briefly,
the assays are based on the detection of cleavage of the
substrate DEVD-AFC (AFC: 7-amino-4-trifluoromethyl
coumarin) by caspase-3 and LEHD-AFC (AFC: 7-amino-
4-trifluoromethyl coumarin) by caspase-9. Uncleaved
DEVD-AFC and LEHD-AFC fluoresce at λmax = 400 nm,
upon cleavage of the respective substrate by caspase-3
or caspase-9, free AFC emits a yellow-green fluorescence
(λmax = 505 nm), which was quantified using a fluores-
cence microplate reader (Tecan Safire, MTX Lab Sys-
tems, Inc., Vienna, VA). Results were expressed as raw
fluorescence units per milligram of cytosolic protein.
Apoptosis cell death detection ELISA
Apoptotic DNA fragmentation was quantified in the skel-
etal muscle (quadriceps femoris), heart, primary
hematopoietic stem cells, and primary satellite cells by
measuring the amount of cytosolic mono- and oligo-
nucleosomes using a Cell Death detection ELISAPLUS
assay (Roche Applied Science, Laval, QC) as previously
described [11]. Briefly, wells were coated with a monoclo-
nal anti-histone antibody and incubated with homoge-
nates. Nucleosomes were centrifuged at 100,000g followed
by binding to the anti-histone antibody followed by the
addition of anti-DNA-peroxidase antibody that binds to
the DNA associated with the histones. The amount of per-
oxidase retained in the immunocomplex was determined
spectrophotometrically with ABTS (2,2′-azino-bis[3-ethyl-
benzthiazoline-6-sulphonic acid]) as a substrate. Results
were expressed as arbitrary OD units normalized to mi-
crograms of cytosolic protein.
Quantification of mtDNA mutations
mtDNA mutations were quantified by the error-resistant
single molecule approach [26]. Briefly, skeletal muscle
(quadriceps femoris) DNA was subjected to limiting dilu-
tion long-range PCR, where each positive PCR reaction
was initiated by a single mtDNA molecule. PCR was de-
signed to amplify essentially the entire mitochondrial
genome using high-fidelity Phusion DNA polymerase,
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(New England Biolabs). Three to 9 amplified molecules
were obtained per animal. Each amplified molecule was
sequenced in its entirety using barcoded Illumina next
generation sequencing approach at a local core facility.
Mutations were identified by comparing each molecule’s
sequence to the standard C57Bl/6J mtDNA sequence
(GenBank EF108336). Only 100 % mutations were con-
sidered, which guaranteed the exclusion of artifacts [26].
Mutant fractions were calculated by dividing the total
number of mutations by the number of nucleotides se-
quenced per animal.
p53 base excision repair activity assay
An in vitro fluorescence-based DNA primer p53 repair
activity assay was employed as previously described [27],
with minor modifications. This assay utilized a double-
stranded deoxyoligomers containing sequences identical
to the first 40 nucleotides of the mtDNA replication ori-
gin as the primer-template substrate, with the 3′ end of
the primer contained self-designed mismatch point mu-
tation in the last three nucleotides (Additional file 1:
Table S2). The 5′ and 3′ ends of the primer were chem-
ically linked to a Black Hole Quencher®-1 and 6-
carboxyfluorescein (FAM-1™) flourophore, respectively
(Integrated DNA Technology®, Toronto, ON). The prem-
ise of this assay is that, in the absence of proofreading
capacity of mitochondrial polymerase gamma, primer
extension requires the excision of the unpaired nucleo-
tides by the 3′→5′ exonuclease activity which in turn
will be detected as an increase in fluorescence over time.
The 20 μL reaction mixtures containing 50 mM Tris–
HCl (pH 7.5), 5 mM MgCl2, 1 mM DTT, 100 μg/mL of
BSA, 3′-end-FAM1™ primer-template substrate, 50 μM
each of dATP, dCTP, dGTP, and dTTP, and 40 μg of
WT, PolG-SED, and PolG-END skeletal muscle (quadri-
ceps femoris) mitochondrial extracts were incubated at
37 °C for 40 min with data collection at the end using
iCycler IQ™ real-time PCR detection system (BioRad,
Mississauga, ON). To assess the requirement of p53 as
an accessory mtDNA mismatch point mutation repair
protein, p53 repair activity assay was also carried out in
(i) PolG-END skeletal muscle mitochondrial extract after
p53 immunodepletion and (ii) PolG-SED skeletal muscle
mitochondrial extract with addition of recombinant hu-
man p53 (BD Biosciences, Mississauga, ON).
Statistics
All molecular indices between the groups (WT, PolG-
SED, PolG-END, PolG-p53 MKO-SED, and PolG-p53
MKO-END mice) were analyzed using two-tailed Stu-
dent’s t test. The log-rank test was used to test for signifi-
cant differences in life span distribution between groups.
Statistical significance was established at a P ≤ 0.05. Data
are presented as mean ± standard error of the mean
(SEM).
Results and discussion
Endurance exercise confers phenotypic protection,
reduces mtDNA mutations, and attenuates oxidative
damage in PolG mice
Aged tissues display stochastic accumulation of mtDNA
mutations that likely perpetuate respiratory chain defi-
ciency and greater reactive oxygen species (ROS)-medi-
ated damage [28]. To evaluate the underlying protective
mechanism of exercise on mitochondrial redox status
and mtDNA integrity, we profiled “terminally differenti-
ated” (skeletal muscle and heart) and “proliferative” (Lin
− Sca-1+ c-Kit + population enriched for hematopoietic
stem and progenitor cells, “HSC’ and c-met+, satellite
cells, “SC”) compartments of littermate wild-type (WT),
sedentary PolG (PolG-SED), and forced-endurance exer-
cised PolG (PolG-END) mice. As shown previously [11],
and now confirmed in an independent cohort of mice
utilized in this study, exercise rescued progeroid aging
(Additional file 1: Figure S1A), increased life span
(Additional file 1: Figure S1B), and reduced mtDNA mu-
tations (Fig. 1a) in PolG mice.
Initial characterization of PolG mice showed absence
of increased oxidative damage despite significant accu-
mulation of mtDNA point mutations [4, 29]. We evalu-
ated the presence of oxidative modifications and found
no difference in protein carbonyls (PC) and 4-hydroxy-
2-nonenal (4-HNE) content in the muscle, heart, and SC
homogenates of PolG-SED vs. WT (Additional file 1:
Figure S1C). We surmised that since the absence of oxi-
dative damage in the PolG tissues is due to cell-to-cell
variability, and that any one modification would be lower
than the detectable limit in whole tissue homogenates
[4, 29], we measured oxidative damage in mitochondrial
fractions—the primary source of cellular ROS. Indeed,
mitochondria from these tissues demonstrated a sub-
stantial increase in H2O2 production, along with elevated
PC and 4-HNE content (Fig. 1b, c, and Additional file 1:
Figure S1C, D, and F). These observations are consistent
with recent studies reporting higher PC levels in heart
mitochondria of PolG mice [30] and increased mito-
chondrial H2O2 production in vivo using mitochondria-
targeted mass spectrometry probe MitoB [31]. This
higher oxidative damage is also congruent with reduced
superoxide dismutase 2 (SOD2) and catalase content
and activity in PolG-SED vs. WT (Fig. 1d and Additional
file 1: Figure S1E). We hypothesize that the combination
of lower antioxidant capacity, coupled with elevated
ROS production in PolG-SED mitochondria exacerbates
the accumulation of mtDNA mutations. Consistent with
this notion, Vermulst et al. reported a significant reduc-
tion in the frequency of mtDNA mutations in the heart
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tissue of transgenic animals that over-expressed human
catalase (CAT), a ROS scavenger, to mitochondria vs.
age-matched (28 months old) wild-type mice [32]. We
observed that exercise normalized mitochondrial H2O2
production (Fig. 1b and Additional file 1: Figure S1D),
and markers of oxidative damage (Fig. 1c and Additional
file 1: Figure S1F) in PolG-END to WT levels and in-
creased SOD2 and catalase content and activity (Fig. 1d
and Additional file 1: Figure S1E). Together, our data
suggest that exercise reduces mtDNA point mutations,
at least in part, via the up-regulation of cellular antioxi-
dant capacity that subsequently serves to attenuate ROS
levels.
Endurance exercise diminishes telomere erosion and
down-regulates aberrant p53 signaling and pathological
levels of apoptosis in PolG mice
Sustained intrinsic accumulation of oxidative damage
has been implicated in telomere erosion that drives
age-related tissue degeneration [1]. In agreement with
this, we observed shorter telomeres in the heart,
HSC, and SC from PolG-SED vs. WT (Fig. 1e).
Genomic instability due to telomere shortening acti-
vates tumor suppressor protein p53-mediated senes-
cence/apoptotic signaling cascades [1]. Accordingly,
nuclear p53 abundance in the muscle, heart, and SC
of PolG-SED was enhanced (Fig. 1f ), concomitantly
with higher expression levels of the p53-responsive
senescence genes: p21WAF1, p16INK4A, and GADD45B
(Additional file 1: Figure S1G) vs. WT. Mitochondrial
dysfunction in PolG mice is associated with patho-
logical systemic apoptosis [4, 11], and consistent with
these observations, we found higher DNA fragmenta-
tion (Fig. 2a) and caspase-3/9 activity (Additional file
1: Figure S2A and B) in PolG-SED mice. Interestingly,
exercise abrogated telomere shortening (Fig. 1e), re-
duced p53 nuclear accumulation (Fig. 1f ), normalized
the expression of p53-responsive senescence genes
(Additional file 1: Figure S1G), and reduced patho-
logical levels of apoptosis in PolG-END (Fig. 2a, and
Additional file 1: Figure S2A and B).
Endurance exercise mitigates mitochondrial dysfunction
via reduction in nuclear p53 that represses PGC-1α
A causal role of mitochondrial-induced oxidative stress
and telomere erosion, secondary to mtDNA mutations,
suggests a direct link between p53 activation and mito-
chondrial dysfunction [5]. Increasing the expression of
PGC-1α, a potent regulator of mitochondrial biogenesis,
positively regulates the expression of antioxidants [33]
and has been touted to attenuate aging-associated sarco-
penia and metabolic dysfunction [34]. This prompted us
to investigate whether activation of p53-mediated senes-
cence signaling attenuates PGC-1α-triggered gene pro-
gramming. We conducted in silico promoter analysis
that identified putative p53 binding elements in the
PGC-1α promoter. These promoter regions were then
cloned into a pGL4 luciferase reporter vector and trans-
fected into p53+/+ and p53−/− mouse embryonic fibro-
blasts (MEFs). A significant repression of PGC-1α-pGL4
reporter activity was observed in the p53+/+ relative to
p53−/− MEFs (Additional file 1: Figure S2C). These re-
sults are consistent with a recent study showing that nu-
clear p53 can directly repress PGC-1α expression and
promote mitochondrial dysfunction [5]. To further test
our hypothesis, we next performed an anti-p53 chroma-
tin immunoprecipitation assay that showed physical en-
richment of nuclear p53 at the PGC-1α promoter of
PolG-SED vs. WT mice (Fig. 2b). Together, these data
suggest that ROS-induced cellular damage prompts the
nuclear accumulation of p53, which in turn activates
p53-responsive senescence genes while simultaneously
repressing the pro-metabolic activity of PGC-1α.
qPCR analyses of the PolG-SED muscle, heart, HSC
and SC confirmed lower expression of PGC-1α and
strong repression of its metabolic networks, including
oxidative phosphorylation, mitochondrial function, glu-
coneogenesis, and fatty acid metabolism vs. WT (Fig. 2c,
and Additional file 1: Figure S2D–G, and Table S1).
Additionally, PolG-SED mice tissues and stem cells have
reduced mtDNA copy number (Fig. 2D and Additional
file 1: Figure S3A), lower mitochondrial complex I and
complex IV enzyme activity (Additional file 1: Figure
(See figure on previous page.)
Fig. 1 Endurance exercise reduces random mtDNA somatic mutations, attenuates mitochondrial ROS-mediated oxidative damage, mitigates
telomere shortening, and reduces nuclear accumulation of p53 in mtDNA mutator mice. a Random mtDNA somatic mutation rate (per 1000
nucleotides of mtDNA) in muscle (quadriceps femoris) WT, PolG-SED, and PolG-END mice (n = 4–5/group). b H2O2 production rate in muscle
mitochondrial fractions of WT, PolG-SED, and PolG-END (n = 5–7/group). Complex I and II substrates: P/M, pyruvate/malate and SUC, succinate
(5 mM each), respectively. Complex I and III inhibitors: ROT, rotenone, and AA, antimycin A (0.5 μM each), respectively. c Protein carbonyls (PC)
content in muscle (tibialis anterior) and heart mitochondrial fractions of WT, PolG-SED, and PolG-END (n = 5–7/group). d SOD2 and catalase
enzyme activity in the muscle (quadriceps femoris) and heart of WT, PolG-SED, and PolG-END (n = 7/group). e Average telomere length ratios in
the heart, hematopoietic stem and progenitor cells (HSC), and satellite cells (SC) of WT, PolG-SED, and PolG-END (n = 6–8/group). f Representative
blots of nuclear p53 content (~53 kDa) in the muscle (quadriceps femoris) and heart of WT, PolG-SED, and PolG-END (n = 5–8/group). Histone H2B
(~14 kDa) was used as a nuclear loading control. (PolG-SED vs. both WT and PolG-END) = *P < 0.05, **P < 0.01; (PolG-END vs. WT) = †P < 0.05. Error
bars represent SEM. AU arbitrary units
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S3B), reduced mitochondrial electron transport chain
subunits protein content (Additional file 1: Figure S3C–
I), and accumulation of swollen, pleomorphic, oversized
mitochondria (Fig. 2e). Endurance exercise decreased
binding of p53 to the PGC-1α promoter (Fig. 2b), and
this effect was accompanied by the maintenance of
mtDNA copy number, increased expression of PGC-1α
and its downstream metabolic network, enhanced mito-
chondrial oxidative capacity, and restoration of mito-
chondrial structural integrity in PolG-END (Fig. 2c–e,
and Additional file 1: Figures S2D–G, Figure S3A–I, and
Table S1). These observations collectively imply that ac-
cumulating mtDNA mutations in PolG-SED mice lead
to an increase in ROS generation that (i) promotes mito-
chondrial dysfunction and telomere damage and (ii) sub-
sequently triggers p53-regulated senescence pathways,
thereby potentiating the loss of somatic and stem cells
via apoptosis. In contrast, exercise reduced mtDNA mu-
tations and maintained the cellular energy and redox
homeostasis thereby circumventing telomere erosion
culminating in the inhibition of accelerated systemic
aging characteristic of PolG mice [3, 4].
Endurance exercise-mediated repair of mtDNA mutations
is p53-dependent
POLG1 is the sole mitochondrial polymerase essential
for mtDNA replication and repair via its 3′→5′ exo-
nuclease activity [35]. Since exercise reduced mtDNA
mutations in PolG mice, which lack proofreading cap-
acity of POLG1, this raised an intriguing possibility that
exercise recruited a POLG1-independent mtDNA repair
pathway(s) [11]. We found that despite elevated p53 nu-
clear abundance in PolG-SED, the total p53 content in
the muscle, heart, and SC homogenates of all groups
was unaltered (Additional file 1: Figure S3J). This indi-
cated that a basal pool of p53 is maintained intra-
cellularly, with the distribution of p53 between the
different subcellular compartments dependant on the
cellular stress milieu [27]. In vitro studies show that in
response to intra- and extra-cellular insults such as
ROS, p53 translocates into the mitochondria where it in-
teracts with the mtDNA and POLG1 [27]. Biochemical
analysis of p53 has revealed an inherent 3′→5′
exonuclease activity that helps p53 promote and main-
tain mitochondrial genomic stability by executing base
excision repair on damaged mtDNA [36]. The role of
mitochondrial p53 in the context of aging remains hith-
erto unknown. Collectively, these observations led us to
hypothesize that in the presence of an error-prone
POLG1, mitochondrial p53 will function as an accessory
fidelity-enhancing component of the mtDNA replication
machinery in PolG mice.
To test our hypothesis, we first assessed the submito-
chondrial localization of p53 in skeletal muscle of WT
mice. Subfractionation of skeletal muscle mitochondria in-
dicated that mitochondrial p53 was primarily localized in
the mitochondrial matrix (Fig. 3a). Next, we measured the
mitochondrial abundance of p53 in our experimental
groups. Unlike PolG-SED, in PolG-END mice, p53 prefer-
entially resided in the mitochondria vs. nuclei of muscle
and heart (Figs. 1f and 3b). To ascertain whether mito-
chondrial ROS levels regulated p53 compartmentalization,
we treated primary fibroblasts with rotenone, a complex I
inhibitor known to increase mitochondrial ROS, and ob-
served a rapid increase in mitochondrial p53 content at
lower dosages without a concomitant increase in nuclear
p53 (Additional file 1: Figure S4A). Intriguingly, with in-
creasing rotenone concentrations, we measured an in-
crease in nuclear p53 abundance (Additional file 1: Figure
S4A) and expression of its downstream targets (p16INK4A
and p21WAF1; Additional file 1: Figure S4B), along with a
concomitant reduction in mitochondrial p53 content
(Additional file 1: Figure S4A), and mtDNA copy number
(Additional file 1: Figure S4C). The increase in nuclear
p53 paralleled the decrease in PGC-1α mRNA expression
(Additional file 1: Figure S5A), further supporting the in-
hibitory effects of p53 on PGC-1α. Furthermore, the up-
regulation of rotenone-evoked nuclear p53 content was
attenuated in fibroblasts pre-treated with a ROS scavenger,
N-acetylcysteine (Additional file 1: Figure S5B), in tandem
with higher PGC-1α mRNA expression (Additional file 1:
Figure S5C). Thus, p53 preferentially shuttles into
mitochondria in response to physiological ROS levels,
which abrogates the negative regulation of PGC-1α as
exerted by p53 residing in the nucleus. Next, we
sought to elucidate if mitochondrial p53 interacted
(See figure on previous page.)
Fig. 2 Endurance exercise prevents dysregulated mitochondrial-induced apoptosis, reduces nuclear p53-mediated repression of PGC-1α, induces
PGC-1α regulated gene networks, restores mtDNA copy number, and normalizes mitochondrial morphology in mtDNA mutator mice. a Nuclear
DNA fragmentation (apoptotic index) in the heart, HSC, and SC of WT, PolG-SED, and PolG-END (n = 7–10/group). b ChIP assay showing reduced
p53 enrichment of PGC-1α promoter (positions −954/−564) with exercise in the muscle and heart of WT, PolG-SED, and PolG-END (n = 6/group).
c Gene expression of PGC-1α and its downstream targets in muscle (quadriceps femoris), d mtDNA copy number normalized to nuclear β-globin
gene in the muscle (soleus) and heart, and e representative electron micrographs of myofibers (quadriceps femoris) and cardiomyocytes (heart)
from WT, PolG-SED, and PolG-END mice (n = 4–7/group). Asterisk (PolG-SED vs. both WT and PolG-END): *P < 0.05, **P < 0.01, ***P < 0.001. Error bars
represent SEM. AU arbitrary units
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with POLG1 and Tfam in the mitochondrial matrix.
We performed co-immunoprecipitation reactions and
found that mitochondrial p53 formed a complex with
POLG1 and Tfam complexed at mtDNA (Fig. 3c–e).
The p53-POLG1-Tfam complex at mtDNA was higher
in PolG-END vs. PolG-SED and WT (Fig. 3c–e).
These observations are consistent with a recent study
reporting p53 translocation to of p53 to the mito-
chondria and subsequent formation of p53-Tfam-
mtDNA complex in skeletal muscle of WT mice in
response to an acute bout of endurance exercise [37].
These results led us to conclude that the preferential
subcellular localization of p53 to mitochondria vs.
nuclear compartment is a “universal” exercise-induced
phenomenon and likely plays a role in mediating
beneficial effects of endurance exercise on improving
mitochondrial content/function and ameliorating
dysfunction.
Since both PolG-SED and PolG-END mice have defect-
ive POLG1 proofreading capacity, we believe that the re-
duction in total mtDNA mutational burden in PolG-END
mice (Fig. 1a) is mediated by mitochondrial p53 levels in
response to endurance exercise. Hence, we sought to
evaluate whether mitochondrial p53 can repair mtDNA
mutations, independent of the proofreading capacity of
POLG1. A fluorescence-based in vitro DNA primer
extension-mutation repair assay displayed an efficient re-
pair of double-stranded oligonucleotides, with artificially
added mismatch point mutations, incubated with ex vivo
muscle mitochondrial extract of PolG-END vs. PolG-SED
(Fig. 4a). PolG-END mitochondria failed to repair these
mutations upon p53 immunodepletion (Fig. 4b), while
addition of recombinant p53 increased PolG-SED mito-
chondrial mutation repair efficiency (Additional file 1:
Figure S6A). Clearly, mitochondrial p53 plays a vital role
in the maintenance of mtDNA integrity in the presence of
defective POLG1 in mutator mice.
However, to conclusively attribute causality to mito-
chondrial p53 in mediating mtDNA repair in vivo in re-
sponse to endurance exercise, a “double genetically altered
mutator mouse model” was needed where changes in
mtDNA mutation burden can be assessed in a background
of p53 over-expression or knockdown. It was unfeasible to
generate PolG mice with over-expression of p53, as previ-
ous work has shown that mice engineered with hyper-
active p53 alleles display show stem cell depletion and
premature aging phenotype themselves [38]. On the other
hand, whole-body p53 knockout mice die prematurely of
cancer [39] and do not breed efficiently with heterozygous
PolgA+/D257A mice, and thus could not be bred with PolG
mice to efficiently study the effects of exercise. Hence, we
created a new genetically modified mutator mouse with
muscle-specific p53 deletion (PolG-p53 MKO). At basal
levels, PolG-p53 MKO-SED mice demonstrated an accel-
erated progeriod phenotype and significant accumulation
of random mtDNA mutations in muscle compared to
PolG-SED mice (Fig. 4e and Additional file 1: Figure S6B).
To our surprise, endurance exercise not only failed to
reduce mtDNA point mutations but also did not rescue
progeroid aging, sarcopenia, exercise intolerance, mito-
chondrial morphology anomalies, and deficits in mito-
chondrial content and function such as mtDNA copy
number, mitochondrial electron transport chain protein
content, and COX activity in skeletal muscle of PolG-p53
MKO mice (Fig. 4c–g and Additional file 1: Figure S6B–
E). This suggests that the exercise-mediated repair of
mtDNA mutations in vivo is dependent on mitochondrial
p53 adjuvant repair capacity. Furthermore, unlike PolG-
END, mitochondrial extracts from PolG-p53 MKO failed
to repair mutations in vitro in the primer extension-
mutation repair assay (Additional file 1: Figure S6F). Thus,
exercise-induced maintenance of mtDNA stability is con-
tingent on mitochondrially localized p53 and represents a
viable therapy for pre-symptomatic patients carrying
POLG1 exonuclease domain mutations known to cause
pathology [35].
Conclusions
Here, we show that exercise promotes mitochondrial
oxidative capacity and cellular redox dynamics via PGC-
(See figure on previous page.)
Fig. 3 Endurance exercise increases the abundance of p53 in mitochondrial matrix where it interacts with mtDNA in a complex with POLG1 and Tfam
in mtDNA mutator mice. a Mitochondrial p53 is primarily localized in the matrix. Muscle mitochondria were subfractionated into outer mitochondrial
membrane (OMM), intermembrane space (IMS), inner mitochondrial membrane (IMM), and matrix (Mx) fractions, and these fractions were
immunoblotted for the compartment-specific proteins TOMM22 (~16 kDa), cytochrome c (~14 kDa), COX-IV (~17 kDa), and CS (~45 kDa), respectively,
and also for p53 (~53 kDa) and Tfam (~24 kDa). Representative blots of b mitochondrial p53 content (~53 kDa) in the muscle and heart of WT, PolG-
SED, PolG-END (n = 6–8/group), c p53 co-immunoprecipitation (IP) followed by immunoblotting (IB) for mitochondrial transcription factor A (Tfam;
~24 kDa) to assess mitochondrial p53-Tfam complex content in muscle and heart mitochondria from WT, PolG-SED, PolG-END (n = 4–5/group), and
d p53 co-IP followed by IB for POLG1 (~140 kDa) to assess mitochondrial p53-POLG1 complex content in muscle and heart mitochondria from WT,
PolG-SED, and PolG-END (n = 6–8/group). VDAC (~32 kDa) was used as a mitochondrial loading control. e p53-POLG1-Tfam complex is bound to
mtDNA (quantified using two independent mtDNA regions: COX-II and cytochrome b) in muscle mitochondrial fractions of WT, PolG-SED, and PolG-
END mice (n = 4–6/group). A non-specific IgG antibody was used as negative control antibody. Asterisk (PolG-SED vs. both WT and PolG-END):
*P < 0.05, **P < 0.01; dagger (PolG-END vs. WT): †P < 0.05. Error bars represent SEM. AU arbitrary units
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1α-mediated expression networks, thus preventing the
accumulation of oxidative damage, abrogating genotoxic
damage, and repressing apoptosis in mutator mice.
Intriguingly, stress-mediated subcellular localization of
the tumor suppressor protein p53 determines its pro- or
anti-survival function and seems indispensible for the
Fig. 4 Endurance exercise-mediated repair of mtDNA mutations is mitochondrial p53-dependent. a A fluorescence-based in vitro DNA primer
extension-mutation repair assay in muscle mitochondrial extracts from WT, PolG-SED, and PolG-END (n = 6–8/group) to assess the excision of the
unpaired artificial point mutations. b p53 immunodepletion prevents mutation repair in muscle mitochondrial extracts from PolG-END (n = 5/
group). A non-specific IgG antibody was used as negative control antibody. c Endurance stress test time to exhaustion in four independent trials
in WT, PolG-SED, PolG-END, PolG-p53 MKO-SED, and PolG-p53 MKO-END mice (n = 5–6/group). d Representative electron micrographs of
myofibers (quadriceps femoris) from WT, PolG-SED, PolG-END, PolG-p53 MKO-SED, and PolG-p53 MKO-END (n = 4/group). e Random mtDNA
somatic mutation rate (per 1000 nucleotides of mtDNA) in muscle (quadriceps femoris) WT, PolG-SED, PolG-END, PolG-p53 MKO-SED, and PolG-
p53 MKO-END mice (n = 3–4/group). f mtDNA copy number in muscle mitochondria from PolG-SED, PolG-END, PolG-p53 MKO-SED, and PolG-p53
MKO-END mice (n = 4–5/group) relative to WT mice (horizontal line). g Cytochrome c oxidase (COX) activity in muscle from WT, PolG-SED, PolG-
END, PolG-p53 MKO-SED, and PolG-p53 MKO-END mice (n = 4–5/group). Asterisk (PolG-SED vs. both WT and PolG-END): *P < 0.05, **P < 0.01, ***P
< 0.001; dagger (PolG-p53 MKO-SED vs. PolG-SED OR PolG-p53 MKO-END vs. PolG-END): †P < 0.05; closed circle (PolG-END vs. PolG-SED): ●P < 0.05,
●●P < 0.01, ●●●P < 0.001. Error bars represent SEM. AU arbitrary units
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exercise-mediated mtDNA repair and mitochondrial bio-
genesis. The work summarized here opens up viable ave-
nues of research in cancer biology where mitochondrial
dysfunction and genomic instability have been impli-
cated [1]. It will be of potential clinical interest to see if
exercise-induced mitochondrial-targeted p53 might rep-
resent a therapeutic intervention for aging-associated
pathologies such as insulin resistance, diabetes, and car-
diovascular diseases, which manifest telomere shortening
in conjunction with mitochondrial dysfunction [40, 41].
Indeed, while exercise and an active lifestyle are the
most prominent therapies to reduce the incidence and
pathogenicity of diabetes, insulin resistance, and cardio-
vascular diseases [42, 43], therapeutic modalities that
promise to recapitulate some of the effects of exercise
warrant further attention. The telomere–p53–PGC-1α
axis provides a molecular basis of how telomere erosion
and mitochondrial dysfunction can modulate systemic
aging of tissues and stem cell compartments. Under-
standing the upstream signaling cascades and posttrans-
lational modifications that promote mitochondrial
localization of p53 may allow for the generation of
pharmaceutical analogs, novel therapeutic strategies to
antagonize mitochondrial genomic decay, and cellular
senescence in age-associated pathologies.
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